Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 1 - 1
Notice Type:
Contract Notice
Published Date:
21 August 2023
Closing Date:
05 August 2025
Location(s):
DE2 BAYERN (DE Germany/DEUTSCHLAND)
Description:
AOK Bayern is seeking non-exclusive discount agreements with pharmaceutical companies for the active ingredient dornase alfa (deoxyribonuclease) through an open house model, with contracts starting from 01.10.2023 and ending on 30.09.2025, and termination possible with one month's notice. Interested companies must submit completed and signed documents either in written form or electronically with a qualified electronic signature by the 5th of each month.
Open house Arzneimittelrabattverträge Dornase alfa (Desoxyribonuclease), ATC R05CB13

See description of procurement

It is not an open procedure, but a so-called open house model! The form for the open procedure is only used because there is no form for the open house model. Contracts concluded in the open house model are not subject to public procurement law due to the lack of a selection decision. Submission to procurement regulations is not associated with the use of this form.

AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active ingredient dornase alfa (deoxyribonuclease), ATC R05CB13, in accordance with Section 130a (8) SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements mentioned below the conclusion of identical and non-individually negotiable discount agreements. The earliest possible start date of the contract is 01.10.2023, all contracts end on 30.09.2025. A contract can be concluded at any time during this period, but no later than 05.08.2025. The contracts can be terminated with one month's notice to the end of the month. In the event of the entry into force of a nationwide or state-specific discount agreement for medicinal products concluded in an open procedure with the active ingredient subject to the contract, the open-house agreements shall automatically cease to be effective for the corresponding term. A contract is concluded with all interested pharmaceutical companies, which prove their suitability by means of a completed and signed self-declaration of reliability.

The pharmaceutical company must submit the completed and signed contract (the authorization of representation of the signatory(s) must result from the extract from the commercial register, otherwise a power of attorney must be submitted) together with the completed and signed annex "Determination of the contractual medicinal products" as well as the completed and signed self-declaration of reliability.

The documents can be

EITHER signed by hand in WRITTEN form

OR ELECTRONICALLY with a qualified electronic signature

can be submitted.

Hand-signed documents in WRITTEN FORM must be sent in 2 copies in the original to the following address:

AOK Bayern - The Health Fund

issuing office SGB V

ZE25

open-house discount contracts

Carl Wery 28

81739 Munich

ELECTRONIC documents with a qualified electronic signature must be submitted via the communication area in the procurement portal www.dtvp.de.

If complete and correct documents are received by the 5th of each month, the contract shall commence on the following next first of the month, otherwise on the first day of the month after next. In the case of hand-signed documents in WRITTEN FORM, the complete, completed and signed documents must be sent in advance by fax (089/62730650151), as a scan to the e-mail address vergabestelle1@by.aok.de or via the communication area in the procurement portal www.dtvp.de within the deadline if the complete and correct original documents in paper form are received by the AOK Bayern, awarding office, by the 10th of the month.

Please note the completion instructions, which are provided under www.dtvp.de with the tender documents.

Interested pharmaceutical companies can apply for the activation of the tender documents in the project room for the open house procedure on the www.dtvp.de portal. A link to the portal can be found in this notice.

Only pharmaceutical companies can be considered as potential contractual partners. The documents of the open-house procedure are only released to pharmaceutical companies as potential contractual partners and are to be treated as strictly confidential. By applying for activation by the companies, the confidential treatment of the documents is confirmed.

Download full details as .pdf
The Buyer:
AOK Bayern - Die Gesundheitskasse
CPV Code(s):
33600000 - Pharmaceutical products